Cargando…

Factors Affecting Community Pharmacist’s Knowledge About Chronic Obstructive Pulmonary Disease (COPD) Management in China: A Cross-Sectional Survey Study

PURPOSE: Chronic obstructive pulmonary disease (COPD) has become a significant risk factor that threatens public health. Many studies have confirmed that the professional services for COPD patients by community pharmacists can improve comprehensive benefits. However, there’s less research investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yuqi, Yao, Dongning, Hu, Hao, Ung, Carolina Oi Lam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718967/
https://www.ncbi.nlm.nih.gov/pubmed/33293806
http://dx.doi.org/10.2147/COPD.S280333
_version_ 1783619596341739520
author Hu, Yuqi
Yao, Dongning
Hu, Hao
Ung, Carolina Oi Lam
author_facet Hu, Yuqi
Yao, Dongning
Hu, Hao
Ung, Carolina Oi Lam
author_sort Hu, Yuqi
collection PubMed
description PURPOSE: Chronic obstructive pulmonary disease (COPD) has become a significant risk factor that threatens public health. Many studies have confirmed that the professional services for COPD patients by community pharmacists can improve comprehensive benefits. However, there’s less research investigating the factors affecting community pharmacists’ knowledge about COPD management. Therefore, this study aimed to investigate the knowledge of COPD among community pharmacists in China and analyze the factors affecting community pharmacist’s knowledge about COPD management. METHODS: This study employed a face-to-face, self-administered questionnaire survey targeting community pharmacists from three cities (Nanjing, Zhuhai, Qingyang) in China. Descriptive statistics, t-test and one-way ANOVA were used for data analysis. RESULTS: Out of the 794 pharmacists surveyed, 177 (22.3%) were completed and valid. The majority (91.0%) of participants had a positive attitude they were responsible for assisting patients to control the disease progression. Among 12 knowledge-related survey questions, only 34 (19.2%) pharmacists answered more than half of them correctly, showing that overall knowledge level of participants was generally low. The overall knowledge level was significantly (P < 0.05) associated with higher academic education, on-the-job training, and pharmacies selling drugs for treating COPD. Regarding medical knowledge, participants got higher accuracy rates at some questions as the symptoms of COPD and identifying the main causative factors but were weak in disease characteristics and guidelines for disease diagnosis. As for medication, participants had a certain understanding of different drugs for COPD and their adverse reactions. For non-drug treatment, participants could not entirely choose the best non-drug treatment for patients, while most of them recognize the importance of pulmonary rehabilitation. CONCLUSION: This research indicated that community pharmacists in China lacked sufficient knowledge about COPD management. It is necessary to improve university education, strengthen on-the-job training, adjust the social insurance system, and develop service guidelines for licensed pharmacists to support their professional services for COPD patients.
format Online
Article
Text
id pubmed-7718967
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-77189672020-12-07 Factors Affecting Community Pharmacist’s Knowledge About Chronic Obstructive Pulmonary Disease (COPD) Management in China: A Cross-Sectional Survey Study Hu, Yuqi Yao, Dongning Hu, Hao Ung, Carolina Oi Lam Int J Chron Obstruct Pulmon Dis Original Research PURPOSE: Chronic obstructive pulmonary disease (COPD) has become a significant risk factor that threatens public health. Many studies have confirmed that the professional services for COPD patients by community pharmacists can improve comprehensive benefits. However, there’s less research investigating the factors affecting community pharmacists’ knowledge about COPD management. Therefore, this study aimed to investigate the knowledge of COPD among community pharmacists in China and analyze the factors affecting community pharmacist’s knowledge about COPD management. METHODS: This study employed a face-to-face, self-administered questionnaire survey targeting community pharmacists from three cities (Nanjing, Zhuhai, Qingyang) in China. Descriptive statistics, t-test and one-way ANOVA were used for data analysis. RESULTS: Out of the 794 pharmacists surveyed, 177 (22.3%) were completed and valid. The majority (91.0%) of participants had a positive attitude they were responsible for assisting patients to control the disease progression. Among 12 knowledge-related survey questions, only 34 (19.2%) pharmacists answered more than half of them correctly, showing that overall knowledge level of participants was generally low. The overall knowledge level was significantly (P < 0.05) associated with higher academic education, on-the-job training, and pharmacies selling drugs for treating COPD. Regarding medical knowledge, participants got higher accuracy rates at some questions as the symptoms of COPD and identifying the main causative factors but were weak in disease characteristics and guidelines for disease diagnosis. As for medication, participants had a certain understanding of different drugs for COPD and their adverse reactions. For non-drug treatment, participants could not entirely choose the best non-drug treatment for patients, while most of them recognize the importance of pulmonary rehabilitation. CONCLUSION: This research indicated that community pharmacists in China lacked sufficient knowledge about COPD management. It is necessary to improve university education, strengthen on-the-job training, adjust the social insurance system, and develop service guidelines for licensed pharmacists to support their professional services for COPD patients. Dove 2020-12-01 /pmc/articles/PMC7718967/ /pubmed/33293806 http://dx.doi.org/10.2147/COPD.S280333 Text en © 2020 Hu et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Hu, Yuqi
Yao, Dongning
Hu, Hao
Ung, Carolina Oi Lam
Factors Affecting Community Pharmacist’s Knowledge About Chronic Obstructive Pulmonary Disease (COPD) Management in China: A Cross-Sectional Survey Study
title Factors Affecting Community Pharmacist’s Knowledge About Chronic Obstructive Pulmonary Disease (COPD) Management in China: A Cross-Sectional Survey Study
title_full Factors Affecting Community Pharmacist’s Knowledge About Chronic Obstructive Pulmonary Disease (COPD) Management in China: A Cross-Sectional Survey Study
title_fullStr Factors Affecting Community Pharmacist’s Knowledge About Chronic Obstructive Pulmonary Disease (COPD) Management in China: A Cross-Sectional Survey Study
title_full_unstemmed Factors Affecting Community Pharmacist’s Knowledge About Chronic Obstructive Pulmonary Disease (COPD) Management in China: A Cross-Sectional Survey Study
title_short Factors Affecting Community Pharmacist’s Knowledge About Chronic Obstructive Pulmonary Disease (COPD) Management in China: A Cross-Sectional Survey Study
title_sort factors affecting community pharmacist’s knowledge about chronic obstructive pulmonary disease (copd) management in china: a cross-sectional survey study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718967/
https://www.ncbi.nlm.nih.gov/pubmed/33293806
http://dx.doi.org/10.2147/COPD.S280333
work_keys_str_mv AT huyuqi factorsaffectingcommunitypharmacistsknowledgeaboutchronicobstructivepulmonarydiseasecopdmanagementinchinaacrosssectionalsurveystudy
AT yaodongning factorsaffectingcommunitypharmacistsknowledgeaboutchronicobstructivepulmonarydiseasecopdmanagementinchinaacrosssectionalsurveystudy
AT huhao factorsaffectingcommunitypharmacistsknowledgeaboutchronicobstructivepulmonarydiseasecopdmanagementinchinaacrosssectionalsurveystudy
AT ungcarolinaoilam factorsaffectingcommunitypharmacistsknowledgeaboutchronicobstructivepulmonarydiseasecopdmanagementinchinaacrosssectionalsurveystudy